AR052155A1 - Compuestos organicos - Google Patents

Compuestos organicos

Info

Publication number: AR052155A1
Authority: AR; Argentina
Prior art keywords: pharmaceutically acceptable; water; insoluble; animal; human
Prior art date: 2004-12-14

Application number

ARP050105195A

Other languages

English (en)

Spanish (es)

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-14

Filing date

2005-12-12

Publication date

2007-03-07

2005-12-12 Application filed by Novartis Ag filed Critical Novartis Ag

2007-03-07 Publication of AR052155A1 publication Critical patent/AR052155A1/es

Links

150000002894 organic compounds Chemical class 0.000 title 1
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 6
229920001169 thermoplastic Polymers 0.000 abstract 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 2
239000013543 active substance Substances 0.000 abstract 2
239000002671 adjuvant Substances 0.000 abstract 2
239000007943 implant Substances 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
206010072064 Exposure to body fluid Diseases 0.000 abstract 1
239000012736 aqueous medium Substances 0.000 abstract 1
230000000975 bioactive effect Effects 0.000 abstract 1
210000001124 body fluid Anatomy 0.000 abstract 1
239000010839 body fluid Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
238000013270 controlled release Methods 0.000 abstract 1
238000012377 drug delivery Methods 0.000 abstract 1
238000011065 in-situ storage Methods 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
239000003960 organic solvent Substances 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
239000004416 thermosoftening plastic Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

ARP050105195A 2004-12-14 2005-12-12 Compuestos organicos AR052155A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04029498		2004-12-14

Publications (1)

Publication Number	Publication Date
AR052155A1 true AR052155A1 (es)	2007-03-07

Family

ID=34927750

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP050105195A AR052155A1 (es)	2004-12-14	2005-12-12	Compuestos organicos

Country Status (16)

Country	Link
JP (1)	JP5372378B2 (pt)
KR (1)	KR101304160B1 (pt)
CN (1)	CN101056617B (pt)
AR (1)	AR052155A1 (pt)
AT (1)	ATE389386T1 (pt)
AU (1)	AU2005315823B2 (pt)
BR (1)	BRPI0519022A2 (pt)
CA (1)	CA2585779C (pt)
DE (1)	DE602005005522T2 (pt)
ES (1)	ES2301084T3 (pt)
MX (1)	MX2007007099A (pt)
NZ (1)	NZ554904A (pt)
RU (1)	RU2394558C2 (pt)
TW (1)	TWI369218B (pt)
WO (1)	WO2006063794A1 (pt)
ZA (1)	ZA200703506B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8852638B2 (en)	2005-09-30	2014-10-07	Durect Corporation	Sustained release small molecule drug formulation
EP2152315B1 (en)	2007-05-25	2016-01-06	Indivior UK Limited	Sustained delivery formulations of risperidone compounds
CN101159064B (zh)	2007-11-29	2010-09-01	腾讯科技（深圳）有限公司	画像生成系统以及按照图像生成画像的方法
US10588855B2 (en)	2008-05-12	2020-03-17	University Of Utah Research Foundation	Intraocular drug delivery device and associated methods
US9877973B2 (en)	2008-05-12	2018-01-30	University Of Utah Research Foundation	Intraocular drug delivery device and associated methods
US10064819B2 (en)	2008-05-12	2018-09-04	University Of Utah Research Foundation	Intraocular drug delivery device and associated methods
JP6543431B2 (ja) *	2013-10-10	2019-07-10	ユニバーシティーオブユタリサーチファウンデーションＵｎｉｖｅｒｓｉｔｙｏｆＵｔａｈＲｅｓｅａｒｃｈＦｏｕｎｄａｔｉｏｎ	眼内薬物送達デバイスおよび付随する方法
PL3609470T3 (pl) *	2017-04-13	2024-04-15	Ceva Santé Animale	Implant do leczenia infekcji pasożytniczej
CN112336682B (zh) *	2020-09-28	2022-07-08	浙江大学	具有缓控释药物作用的可注射复合载体与组合物及制备方法
WO2024003291A1 (en)	2022-06-30	2024-01-04	Virbac	Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4938763B1 (en) *	1988-10-03	1995-07-04	Atrix Lab Inc	Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) *	1989-07-24	1994-06-28	Atrix Laboratories, Inc.	Biodegradable polymer composition
ATE318580T1 (de) *	1996-12-20	2006-03-15	Alza Corp	Gelzusammensetzungen und verfahren
WO1999042147A1 (en) *	1998-02-23	1999-08-26	Massachusetts Institute Of Technology	Biodegradable shape memory polymers
KR100684055B1 (ko) *	1998-03-19	2007-02-16	머크 앤드 캄파니 인코포레이티드	생물활성 물질의 방출 조절용 액체 중합체성 조성물
US7128927B1 (en) *	1998-04-14	2006-10-31	Qlt Usa, Inc.	Emulsions for in-situ delivery systems
JP4317606B2 (ja) *	1998-09-18	2009-08-19	サンスター株式会社	固体粒子形成用組成物
US7368126B2 (en) *	2002-11-06	2008-05-06	Guohua Chen	Controlled release depot formulations
WO2004081196A2 (en) *	2003-03-11	2004-09-23	Qlt Usa Inc.	Formulations for cell- schedule dependent anticancer agents

2005
- 2005-12-12 AR ARP050105195A patent/AR052155A1/es unknown
- 2005-12-12 TW TW094143807A patent/TWI369218B/zh not_active IP Right Cessation
- 2005-12-13 DE DE602005005522T patent/DE602005005522T2/de not_active Expired - Lifetime
- 2005-12-13 AU AU2005315823A patent/AU2005315823B2/en not_active Ceased
- 2005-12-13 BR BRPI0519022-3A patent/BRPI0519022A2/pt not_active IP Right Cessation
- 2005-12-13 AT AT05815330T patent/ATE389386T1/de not_active IP Right Cessation
- 2005-12-13 JP JP2007545931A patent/JP5372378B2/ja not_active Expired - Fee Related
- 2005-12-13 CN CN2005800386792A patent/CN101056617B/zh not_active Expired - Fee Related
- 2005-12-13 NZ NZ554904A patent/NZ554904A/en not_active IP Right Cessation
- 2005-12-13 ES ES05815330T patent/ES2301084T3/es not_active Expired - Lifetime
- 2005-12-13 MX MX2007007099A patent/MX2007007099A/es active IP Right Grant
- 2005-12-13 RU RU2007126759/15A patent/RU2394558C2/ru not_active IP Right Cessation
- 2005-12-13 CA CA2585779A patent/CA2585779C/en not_active Expired - Fee Related
- 2005-12-13 KR KR1020077013264A patent/KR101304160B1/ko not_active Expired - Fee Related
- 2005-12-13 WO PCT/EP2005/013377 patent/WO2006063794A1/en not_active Ceased
2007
- 2007-05-02 ZA ZA200703506A patent/ZA200703506B/xx unknown

Also Published As

Publication number	Publication date
KR101304160B1 (ko)	2013-09-04
CA2585779C (en)	2014-01-28
TW200635616A (en)	2006-10-16
DE602005005522D1 (de)	2008-04-30
KR20070092964A (ko)	2007-09-14
MX2007007099A (es)	2007-06-22
AU2005315823B2 (en)	2009-06-04
AU2005315823A1 (en)	2006-06-22
WO2006063794A1 (en)	2006-06-22
JP2008523131A (ja)	2008-07-03
TWI369218B (en)	2012-08-01
CA2585779A1 (en)	2006-06-22
CN101056617B (zh)	2012-07-11
RU2007126759A (ru)	2009-01-27
ZA200703506B (en)	2008-09-25
JP5372378B2 (ja)	2013-12-18
RU2394558C2 (ru)	2010-07-20
DE602005005522T2 (de)	2009-04-16
ATE389386T1 (de)	2008-04-15
BRPI0519022A2 (pt)	2008-12-23
ES2301084T3 (es)	2008-06-16
NZ554904A (en)	2009-11-27
CN101056617A (zh)	2007-10-17

Similar Documents

Publication	Publication Date	Title
CA2273017C (fr)	2008-09-16	Dispositif d'administration locale de formulations solides ou semi-solides, formulations retard pour administration parenterale et procede de preparation
Almeida et al.	2012	Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): Main features and their applications in topical and transdermal administration of drugs
TWI377958B (en)	2012-12-01	In-situ gelling drug delivery system
ES2359973T3 (es)	2011-05-30	Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
RU2009111715A (ru)	2010-10-10	Устройство для локальной и/или региональной доставки с применением жидких составов терапевтически активных веществ
CA2468703A1 (en)	2003-06-05	Controlled release polymeric compositions of bone growth promoting compounds
ES2116308T5 (es)	2007-12-01	Procedimiento para la produccion de un dispositivo implantable a base de un material polimero, que contiene principios activos farmaceuticos.
JP2017522365A (ja)	2017-08-10	薬物送達システム及び関連する使用方法
WO2006041942A3 (en)	2009-04-23	Ocular delivery of polymeric delivery formulations
NZ597621A (en)	2013-06-28	Sustained delivery formulations of risperidone compounds
JP2011093944A (ja)	2011-05-12	生体分解性徐放性ドラッグデリバリーシステム
DK1660034T3 (da)	2009-05-11	Fremstilling af langtidsafgivende medikamentindretninger af polyurethanbaserede polymerer
DE60209446D1 (de)	2006-04-27	Medizinische Implantatvorrichtung , Einführgerät und Implantierungsverfahren für ein Wirkstoff und Zellen enthaltendes Implantat
RU2463079C2 (ru)	2012-10-10	Разделительные агенты для имплантируемого устройства и способы их применения
JP2009510048A (ja)	2009-03-12	ゲル化疎水性注入ポリマー組成物
RU2015109296A (ru)	2016-10-20	Системы доставки лекарственного средства и способы лечения рака мочевого пузыря, включающие применение оксалиплатина
HRP20221252T1 (hr)	2022-12-09	Sustavi isporuke lijeka i postupci za liječenje raka mokraćnog mjehura s gemcitabinom
AR118753A1 (es)	2021-10-27	Método de tratamiento de un niño con pubertad precoz central usando una composición de liberación prolongada
ES2301084T3 (es)	2008-06-16	Implante de formacion in situ para animales.
ES2433085T3 (es)	2013-12-09	Composición acuosa lubricante
Liu et al.	2011	Paclitaxel-loaded expansile nanoparticles delay local recurrence in a heterotopic murine non-small cell lung cancer model
AR053799A1 (es)	2007-05-23	Composiciones que contienen policonasol y teaflavina y sus usos farmaceuticos
TH79952A (th)	2006-09-14	สารอินทรีย์
JP2004534618A (ja)	2004-11-18	再狭窄に対するビトロネクチン受容体アンタゴニストを有するステント

Legal Events

Date	Code	Title	Description
2016-11-10	FB	Suspension of granting procedure